| University of Missouri at Kansas City School of Medicine | ||
| City: Kansas City | State: MO | |
|
Links:
Commentary:Misourri_KC_COI_Policy.pdf MedIndlInteract6-25-08.pdf Missouri_KC_COI_w_fed_grant_agencies.pdf Policies_and_Procedures_Manual_2008.pdf Medical_Industry_Interaction.pdf Summary: University of Missouri at Kansas City School of Medicine provides a good policy which prevents acceptance of gifts of any value, including meals. Industry representatives are only permitted on the premises by appointment. Gifts to the institution and support for education are to be received and controlled by the institution's CME offices. Unfortunately, both the Disclosure and Industry Speaking Relationships policies are lacking. Their Disclosure policies only require faculty to disclosure level conflicts of interest above $10,000. Policies on speaking relationships may indeed be more stringent than what we have graded them, but they have not provided us these policies. Finally, there is no enforcement or penalties cited. Demographics: On average students spend 80% of their training at Truman Medical Center and the remainder at Saint Luke’s Hospital and Children’s Mercy Hospital. The submitted policies apply to the school of medicine, Truman Medical Center, and affiliated behavioral health and family practice sites but not Saint Luke’s Hospital or Children’s Mercy Hospital. Updates This institution did not submit any new or additional policies for the 2012-13 AMSA PharmFree Scorecard.
This institution's evaluation was last updated: 2/03/2012. |
||
| Gifts & Meals | ![]() |
All meals and gifts are prohibited. |
| Consulting relationships | ![]() |
Institutional review and a formal contract are required for consulting relationships. |
| Industry-funded speaking relationships | ![]() |
The institution does not provide specific limits on speaking relationships. |
| Disclosure | ![]() |
The policy requires that disclosure of significant financial interest be made by covered individuals engaged in research at the institution. Personnel are also required to disclose conflicts to their supervisors in writing but not on a periodic basis. |
| Pharmaceutical samples | ![]() |
Samples are not to be dispensed by covered persons (employees) directly but may only be received and dispensed by the pharmacy department. They may be signed for by physicians but in non-clinical areas. |
| Purchasing & Formularies | ![]() |
Pharmacy and therapeutics committee members must disclose only {significant" financial relationships (usually of $10,000 or more) to the committee. |
| Industry Sales Representatives | ![]() |
Pharmaceutical industry representatives may only be present in non clinical areas after paying an annual fee and receiving a name badge for each visit. |
| On-campus Education | ![]() |
Support for CME activities with the institution are to strictly follow ACCME standards. |
| Attendance at Industry-Sponsored Lectures & Meetings Off-Campus | ![]() |
Acceptance of compensation of any kind for attendance at an event is prohibited. |
| Industry Support for Scholarships & Funds for Trainees | ![]() |
Industry support for the education of covered persons are to be directed to the institution's CME offices. The institution is responsible for the selection of the recipient. |
| Medical school curriculum | ![]() |
All covered persons receive training on conflicts of interest and interactions with industry, although it is not part of the curriculum. |
| Do the policies specify an oversight mechanism? | ![]() |
There is no mechanism for oversight and compliance |
| Are there explicit sanctions for noncompliance? | ![]() |
There are no clear sanctions for non-compliance |
| Model policy | |
| Good progress toward model policy | |
| No policy, or policy unlikely to have a substantial effect on behavior | |
| Did not report | |
| Policy not relevant to this institution (e.g., does not make purchasing decisions) | |